Complete Filing Data
Quantum Biopharma Ltd. reported Cash And Cash Equivalents of $1.91 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Quantum Biopharma Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Research And Development Expense | $2.8M | $6.1M | $3.9M | $6.9M | $6.3M | $7.8M | $0.00 |
| Interest Revenue Expense | $236.1K | $572.9K | $786.4K | $367.7K | $1.3K | $3.7K | |
| Comprehensive Income | -$27.0M | -$14.9M | -$18.2M | -$23.6M | -$35.3M | -$31.5M | -$39.2M |
| Profit Loss From Continuing Operations | -$27.0M | -$14.9M | -$18.2M | -$26.7M | -$33.9M | -$28.5M | -$34.1M |
| Profit Loss Attributable To Noncontrolling Interests | -$27.0M | -$14.9M | -$18.2M | -$23.6M | -$35.3M | ||
| Profit Loss From Operating Activities | -$15.3M | -$16.1M | -$23.8M | -$27.4M | -$33.7M | -$30.7M | -$22.5M |
| General And Administrative Expense | $9.4M | $9.0M | $14.5M | $15.9M | $10.1M | $8.4M | |
| Profit Loss | -$23.6M | -$35.3M | -$31.8M | -$39.1M | |||
| Profit Loss Attributable To Ordinary Equity Holders Of Parent Entity Including Dilutive Effects | -$26.2M | -$14.2M | -$17.9M | -$23.6M | -$35.3M | ||
| Other Comprehensive Income | -$26.9M | -$15.3M | -$18.5M | -$23.2M | -$35.3M | ||
| Comprehensive Income Attributable To Noncontrolling Interests | -$781.6K | -$712.8K | -$328.4K | $0.00 | $0.00 | ||
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $40.7K | -$366.5K | -$235.3K | $413.0K | $31.8K | $292.6K | -$84.8K |
| Impairment Loss | $0.00 | $0.00 | $4.6M | $0.00 | $0.00 | ||
| Adjustments For Interest Expense | $65.7K | $9.3K | $24.3K | $63.4K | $69.4K | $7.9K | $155.3K |
| Profit Loss From Discontinued Operations | $0.00 | $0.00 | $3.1M | -$1.3M | -$3.3M | -$5.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $1.9M | $6.0M | $2.8M | $17.0M | $35.3M | $17.5M | $6.0M | $15.9M |
| Cash Flows From Used In Operating Activities | -$8.2M | -$6.9M | -$10.8M | -$28.3M | -$20.7M | -$19.1M | -$13.7M | |
| Cash Flows From Used In Investing Activities | -$2.0M | -$1.5M | -$269.6K | $12.1M | $269.0K | $6.5M | -$230.9K | |
| Cash Flows From Used In Financing Activities | $6.1M | $11.6M | -$3.1M | -$2.1M | $38.2M | $24.2M | $4.0M | |
| Adjustments For Decrease Increase In Trade And Other Receivables | $196.7K | -$145.9K | $159.6K | $215.2K | -$106.9K | $435.2K | -$387.8K | |
| Rightofuse Assets | $102.3K | $53.5K | $32.8K | $155.2K | $168.3K | $0.00 | $95.9K | |
| Retained Earnings | -$198.3M | -$172.1M | -$157.9M | -$144.2M | -$126.2M | -$90.9M | ||
| Liabilities | $6.1M | $6.7M | $4.6M | $7.9M | $8.8M | $5.7M | ||
| Intangible Assets Other Than Goodwill | $4.5M | $4.9M | $5.4M | $12.0M | $16.2M | $13.4M | ||
| Equity And Liabilities | $11.2M | $17.1M | $17.5M | $38.4M | $63.0M | $42.0M | ||
| Current Assets | $6.5M | $12.1M | $11.1M | $17.9M | $45.9M | $26.9M | ||
| Assets | $11.2M | $17.1M | $17.5M | $38.4M | $63.0M | $42.0M | ||
| Property Plant And Equipment | $67.0K | $76.9K | $87.6K | $105.7K | $0.00 | |||
| Current Liabilities | $6.1M | $6.7M | $4.6M | $7.8M | $8.7M | $5.6M | ||
| Current Lease Liabilities | $103.2K | $53.8K | $38.7K | $177.9K | $124.3K | $46.8K | ||
| Adjustments For Increase Decrease In Trade And Other Payables | $4.3M | $2.0M | -$699.8K | $3.6M | $898.7K | $1.5M | ||
| Adjustments Change In Fair Value Of Investments | $258.0K | -$3.7K | -$378.4K | $234.2K | $858.5K | |||
| Current Investments | $459.1K | $1.2M | $756.1K | $0.00 | $158.0K | $0.00 | ||
| Issue Of Equity | $391.4K | $10.7M | $38.3M | $22.1M | $8.7M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.0M | $2.8M | $17.0M | $35.3M | $17.5M | |||
| Unrealized Loss On Change In Fair Value Of Digital Assets | -$771.9K | -$141.8K | $0.00 | $0.00 | ||||
| Trade And Other Current Payables | $4.2M | $4.4M | $7.1M | $7.5M | $3.7M | |||
| Gain On Settlement Of Debt | $43.3K | $732.4K | $0.00 | $0.00 | ||||
| Purchase Of Intangible Assets Classified As Investing Activities | $0.00 | $0.00 | $250.0K | $500.0K | $0.00 | $293.1K | ||
| Other Receivables | $231.1K | $374.7K | $228.8K | $374.4K | ||||
| Noncurrent Investments | $0.00 | $2.2K | $6.0K | $827.6K | ||||
| Equity Attributable To Owners Of Parent | $6.9M | $11.5M | $13.2M | $30.5M | ||||
| Current Finance Lease Receivables | $0.00 | $3.4M | $7.2M | $0.00 | ||||
| Gains Losses On Financial Liabilities At Fair Value Through Profit Or Loss | $0.00 | $0.00 | -$22.6K | $0.00 | ||||
| Cash Flows From Used In Operating Activities Discontinued Operations | $0.00 | $0.00 | -$1.1M | -$1.4M | -$737.7K | -$6.6M | ||
| Cash Flows From Used In Operating Activities Continuing Operations | -$6.9M | -$10.8M | -$27.2M | -$19.4M | -$18.4M | -$7.1M | ||
| Cash Flows From Used In Investing Activities Discontinued Operations | $0.00 | $0.00 | $12.7M | $0.00 | $36.6K | -$401.8K | ||
| Cash Flows From Used In Investing Activities Continuing Operations | -$1.5M | -$269.6K | -$607.5K | $269.0K | $6.5M | $170.9K | ||
| Cash Flows From Used In Financing Activities Continuing Operations | $11.6M | -$3.1M | -$2.1M | $38.2M | $24.2M | $4.0M | ||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $0.00 | $0.00 | $114.0K | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Proceeds From Issuing Shares | 338.3K | 10.7M | 34.00 | 0.00 | 38.3M | 25.1M | 3.4M |
| Payments Of Lease Liabilities Classified As Financing Activities | $113.9K | $63.6K | $189.1K | $143.1K | $57.6K | $40.0K | $42.3K |
| Proceeds From Exercise Of Options | $148.1K | $0.00 | $20.2K | $0.00 | $0.00 | $59.5K | $551.1K |
| Proceeds From Sales Of Investment Property | $460.5K | $0.00 | $0.00 | $158.0K | $0.00 | ||
| Increase Decrease In Cash And Cash Equivalents | -$4.1M | $3.2M | -$14.2M | -$18.3M | $17.7M | $11.6M | -$9.9M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjusted Weighted Average Shares | 1.1M | 609.1K | 595.9K | 34.9M | 12.0M | 7.1M | |
| Basic Earnings Loss Per Share From Continuing Operations | $-8.20 | $-13.12 | $-29.93 | $-0.69 | $-0.97 | $-2.36 | $-4.83 |
| Basic Earnings Loss Per Share From Continuing Operations Basic Earnings Loss Per Share From Continuing Operations | $-13.12 | $-29.93 | $-44.81 | $-0.97 | |||
| Diluted Earnings Loss Per Share From Continuing Operations | $-8.20 | $-13.12 | $-29.93 | $-0.69 | $-0.97 | $-2.36 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Expense From Sharebased Payment Transactions With Employees | $2.9M | $152.2K | $3.8M | $1.5M | $7.4M | $8.1M | $12.1M |
| Depreciation And Amortisation Expense | $545.8K | $490.6K | $2.5M | $4.5M | $4.0M | $3.9M | $1.9M |
| Finance Costs | $158.1K | $33.0K | $299.00 | $48.8K | $69.4K | $235.6K | $155.3K |
| Gains Losses On Change In Fair Value Of Derivatives | -$11.9M | $104.5K | $212.3K | -$521.8K | -$682.5K | $2.6M | -$2.7M |
| Adjustments For Depreciation And Amortisation Expense | $545.8K | $490.6K | $2.5M | $4.5M | $4.0M | $3.9M | $1.9M |
| Operating Expense | $15.3M | $16.1M | $23.8M | $27.4M | $33.7M | ||
| Share Premium | $35.4M | $31.1M | $30.2M | $28.5M | $22.6M | $18.8M | |
| Current Prepaid Expenses | $15.3K | $69.0K | $155.4K | $472.1K | $1.4M | $569.4K | |
| Purchase Of Investment Property | $462.3K | $6.7M | $744.5K | $401.6K | $0.00 | $0.00 | |
| Other Income | $1.9M | $4.0K | $0.00 | $0.00 | $1.3K | $3.7K | $40.5K |
| Reserve Of Exchange Differences On Translation | $91.5K | $50.8K | $417.3K | $652.6K | $239.6K | $207.8K | |
| Adjustments For Finance Income | -$1.5M | -$4.7M | $663.7K | $7.4M | $0.00 | $0.00 | |
| Increase Decrease Through Sharebased Payment Transactions | $2.9M | $152.2K | $2.5M | $1.5M | $7.4M | $9.4M | $551.1K |
| Losses On Change In Fair Value Of Derivatives | $117.1K | $0.00 | $0.00 | $234.2K | $858.5K | ||
| Noncontrolling Interests | -$1.8M | -$1.0M | -$327.5K | $0.00 | |||
| Adjustments For Sharebased Payments | $2.9M | $152.2K | $3.8M | $1.5M | $7.4M | $8.1M | $12.1M |
| Increase Decrease Through Exercise Of Options | $0.00 | $20.2K | $0.00 | $0.00 | $59.6K | $12.1M | |
| Warrant Reserve | $10.0K | $2.0M | $2.7M | $2.1M | |||
| Inventories | $52.1K | $117.2K | $0.00 | ||||
| Gains Losses On Exchange Differences On Translation Net Of Tax | -$366.5K | -$235.3K | $413.0K | $31.8K |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.